Marie Skłodowska-Curie Actions Postdoctoral Fellowships 2022 at HT
Human Technopole is looking for enthusiastic postdoctoral researchers interested in applying for Marie Skłodowska-Curie Actions Postdoctoral Fellowships 2022.
Projects should focus on one of the areas of the five HT’s Research Centres: Computational Biology, Structural Biology, Genomics, Neurogenomics and Health Data Science.
The objective of PFs is to support researchers’ careers and foster excellence in research. The Postdoctoral Fellowships action targets researchers holding a PhD who wish to carry out their research activities abroad, acquire new skills and develop their careers. PFs help researchers gain experience in other countries, disciplines and non-academic sectors.
The fellowship typically covers the researcher’s salary (living and mobility allowance) for two years, research, training and networking activities costs and overheads for the host institution.
Eligibility criteria
- The researcher must hold a doctoral degree with no more than 8 years of experience after the completion of their PhD
- The researcher can be of any nationality
- The researcher must not have resided or carried out his/her main activity (work, studies, etc.) in Italy for more than twelve months in the three years immediately prior to the call deadline
How to apply
Please apply, indicating the Research Group of interest, by sending your CV and a brief outline of the proposed research project describing how it synergizes with the Research Centre and Group (1 page maximum) to MSCA@fht.org by June 30th 2022.
Potential candidates will be internally pre-selected and notified of the outcome of their application by July 15th 2022, in order to proceed with the official MSCA-PF application (deadline September 14th 2022). Selected applicants will develop their MSCA-PF proposal in cooperation with the proposed supervisor.
Benefits
- A living allowance
- A mobility allowance
- If applicable, family, long-term leave, and special needs allowances
- Funding for research, training, and networking activities
- Management and indirect costs (to the host institution)
For more details on the research areas of interest visit Euraxess
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.